Clinical Trial Update: TAK-935 Multiple Rising Dose Study in Healthy Participants [Phase 1]

View source ↗

Summary

Takeda's TAK-935 Phase 1 multiple rising dose study in healthy participants has completed and results were posted in July 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• TAK-935

Snippet

Sponsor: Takeda | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2017-07-12